Krka, d. d.
KRK
Hisse Senetlerindeki Sıralama
#2123
Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved... Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved in the research, production, promotion, and sale of various pharmaceutical goods. Its market presence spans Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and numerous other international territories. The company's offerings are categorized into prescription medications, over-the-counter products, and veterinary health solutions. Its prescription drug pipeline targets a broad spectrum of medical conditions, including cardiovascular disorders, gastrointestinal issues, central nervous system ailments, pain management, anti-infective treatments, conditions affecting blood and blood-forming organs, urological problems, diabetes, and oncology. The array of non-prescription items includes products for oral and throat care, cough and cold remedies, analgesics, nasal preparations, vitamin and mineral supplements, products designed to enhance cerebral and peripheral circulation, digestive aids, and various general healthcare products. Furthermore, Krka supplies animal health products such as anti-infectives, antiparasitics, and other specialized formulations for both livestock and companion animals. Beyond its pharmaceutical operations, the company also provides health resort and tourist services. Krka, d. d. was established in 1954 and has its corporate headquarters in Novo Mesto, Slovenia.
Hisse Fiyatı
$318.12
Piyasa Değeri
$9.63B
Değişim (1 gün)
0.18%
Değişim (1 yıl)
32.75%
Ülke
SI
Ticaret Krka, d. d. (KRK)
Kategori
Healthcare
Krka, d. d. (KRK) için temettü verimi geçmişi
Krka, d. d. (hisse sembolü: KRK) temettü verimi (TTM) 2023-12-31 itibariyle: 6.44%
Son 5 yılın ortalama temettü verimi: 5.34%
Son 5 yılın ortalama temettü verimi: 5.34%
Krka, d. d. (KRK) için 2010 - 2026 arası temettü verimi geçmişi
Her yılın sonunda temettü verimi (TTM)
| Yıl | Temettü Verimi | Değiştir |
|---|---|---|
| 2026 (TTM) | 3.51% | -35.95% |
| 2024 | 5.48% | -14.91% |
| 2023 | 6.44% | 6.10% |
| 2022 | 6.07% | 45.22% |
| 2021 | 4.18% | -7.32% |
| 2020 | 4.51% | 1.81% |
| 2019 | 4.43% | -12.45% |
| 2018 | 5.06% | 2.64% |
| 2017 | 4.93% | 4.45% |
| 2016 | 4.72% | 25.53% |
| 2015 | 3.76% | 2.45% |
| 2014 | 3.67% | 37.45% |
| 2013 | 2.67% | -3.96% |
| 2012 | 2.78% | -6.40% |
| 2011 | 2.97% | 43.48% |
| 2010 | 2.07% | 0.00% |
Benzer şirketler veya rakiplerin temettü verimi (TTM)
| Şirket | Temettü Verimi | Ülke |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
